Conclusion
Porcine surfactant at 200mg/kg had similar combined outcomes of death/ CLD and redosing compared to bovine surfactant in preterm >28 weeks. Considering the cost burden in the developing world, with no added advantage of using higher doses of porcine surfactant over bovine surfactant, there is an urgent need to evaluate the efficacy in randomised clinical trials.